Returns | |
1 month return | 2.24% |
3 month return | 6.38% |
1 year return | 29.88% |
5 year return | 56.11% |
Organization | Pfizer Inc. |
Employees | 78500 |
CEO | Albert Bourla |
Industry | Health Technology |
Current
$52.75
Target
$60.81
Current | 1M Ago | 3M Ago | |
Buy | 16 | 16 | 13 |
Hold | 14 | 13 | 15 |
Sell | 0 | 0 | 0 |
Consensus | BUY | BUY | HOLD |
Market Capitalization | 280.9B |
Book Value | 13.74 |
Dividend Share | 1.56 |
Dividend Yield | 1.56 |
Earnings Share | 3.85 |
PE Ratio | 12.9061 |
PEG Ratio | 1.17 |
Wall Street Target Price | 60.29 |
Trailing PE | 12.91 |
Forward PE | 6.96 |
Price/Sales (ttm) | 3.46 |
Price/Book (mrq) | 3.52 |
Enterprise Value | 277.8B |
Enterprise Value/Revenue | 3.42 |
Enterprise Value/Ebitda | 9.02 |
Beta | 0.72 |
50 Day MA | 50.67 |
200 Day MA | 49.17 |
Rating Date | 2019-01-01 |
Total Esg | 33.15 |
Total Esg Percentile | 60.0 |
Environment Score | 7.0 |
Environment Score Percentile | 6.0 |
Social Score | 18.47 |
Social Score Percentile | 6.0 |
Governance Score | 13.68 |
GovernanceScorePercentile | 6.0 |
Controversy Level | 3.0 |